S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
OTCMKTS:OSIR

Osiris Therapeutics (OSIR) Stock Forecast, Price & News

$18.99
0.00 (0.00%)
(As of 04/17/2019)
Compare
Today's Range
$18.99
$18.99
50-Day Range
$18.99
$18.99
52-Week Range
$7.01
$19.30
Volume
N/A
Average Volume
205,753 shs
Market Capitalization
$655.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

OSIR stock logo

About Osiris Therapeutics (OTCMKTS:OSIR) Stock

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Receive OSIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OSIR Stock News Headlines

Tissue Engineering Global Market Report 2023
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
Vesselon Discovery Protects and Expands Drug Franchises
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
Stem Cells Market Growth Opportunities Till 2030
Stem Cell Therapy Market Research | 2023-2030
See More Headlines

OSIR Price History

Industry, Sector and Symbol

Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
OTCMKTS:OSIR
Previous Symbol
NASDAQ:OSIR
CUSIP
68827R10
Fax
N/A
Employees
N/A
Year Founded
1992

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$655.69 million
Optionable
Optionable
Beta
N/A

Social Links


Key Executives

  • Mr. Jason Keefer (Age 46)
    Interim Pres & CEO
  • Dr. Alla N. Danilkovitch (Age 54)
    Chief Scientific Officer
  • Mr. Joel David Rogers (Age 56)
    Interim Chief Financial Officer
  • Mr. Edward Yip
    Chief Legal Officer & Corp. Sec.
  • Mr. Laine Dyess
    VP of Sales













OSIR Stock - Frequently Asked Questions

How have OSIR shares performed in 2023?

Osiris Therapeutics' stock was trading at $18.99 at the beginning of 2023. Since then, OSIR shares have increased by 0.0% and is now trading at $18.99.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Osiris Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Aerie Pharmaceuticals (AERI), Cytokinetics (CYTK) and Depomed (DEPO).

What is Osiris Therapeutics' stock symbol?

Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR."

How do I buy shares of Osiris Therapeutics?

Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Osiris Therapeutics' stock price today?

One share of OSIR stock can currently be purchased for approximately $18.99.

How much money does Osiris Therapeutics make?

Osiris Therapeutics (OTCMKTS:OSIR) has a market capitalization of $655.69 million.

How can I contact Osiris Therapeutics?

Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The official website for the company is www.osiristx.com. The biotechnology company can be reached via phone at 443-545-1800 or via email at osirispr@osiris.com.

This page (OTCMKTS:OSIR) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -